In addition, given the expression of TIM3 ligands in GBM and NK cell infiltration [13,50], it is easy to think that the TIM3 knockout NK cells in the present study should exhibit anti-tumor effects on GBM in the clinical setting. This evidence concerns the gene HAVCR2 and glioblastoma.